Edition:
United Kingdom

Avinger Inc (AVGR.OQ)

AVGR.OQ on NASDAQ Stock Exchange Global Market

0.24USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.24
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
327,830
52-wk High
$4.55
52-wk Low
$0.21

Chart for

About

Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascul... (more)

Overall

Beta: --
Market Cap(Mil.): $7.83
Shares Outstanding(Mil.): 23.91
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 168.71 16.44
EPS (TTM): -- -- --
ROI: -- 9.50 10.62
ROE: -- 14.87 14.20

BRIEF-Avinger Says Executive Chairman John Simpson Will Be Leaving Company

* AVINGER INC - JOHN B. SIMPSON, FOUNDER AND EXECUTIVE CHAIRMAN OF AVINGER, WILL BE LEAVING COMPANY

11 Dec 2017

BRIEF-Avinger Q3 loss per share $0.43

* Avinger Inc - ‍cash and cash equivalents totaled $10.2 million as of Sept 30, 2017, compared to $14.0 million as of June 30, 2017​ Source text for Eikon: Further company coverage:

09 Nov 2017

BRIEF-Avinger enters common stock purchase agreement for up to $15.0 mln with Lincoln Park Capital

* Avinger enters into common stock purchase agreement for up to $15.0 million with Lincoln Park Capital Source text for Eikon: Further company coverage:

06 Nov 2017

BRIEF-Avinger receives CE marking approval for in-stent restenosis treatment

* Avinger receives CE marking approval for in-stent restenosis treatment indication with pantheris image-guided atherectomy

26 Sep 2017

BRIEF-Avinger Q2 loss per share $0.54

* Q2 revenue fell 47 percent to $2.5 million Source text for Eikon: Further company coverage:

08 Aug 2017

Earnings vs. Estimates